首页> 外文OA文献 >The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells
【2h】

The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells

机译:白三烯B4受体作为一种介导新的HIV-1分离株进入CD4阳性细胞的新型共受体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The recently cloned human chemoattractant receptor-like (CMKRL)1, which is expressed in vivo in CD4-positive immune cells, has structural homology with the two chemokine receptors C-C chemokine receptor (CCR)5 and C-X-C chemokine receptor (CXCR)4, which serve as the major coreceptors necessary for fusion of the HIV-1 envelope with target cells. In view of the structural similarity, CMKRL1 was tested for its possible function as another HIV-1 coreceptor after stable expression in murine fibroblasts bearing the human CD4 receptor. The cells were infected with 10 primary clinical isolates of HIV-1, and entry was monitored by semiquantitative PCR of viral DNA. The efficiency of the entry was compared with the entry taking place in CD4-positive cells expressing either CCR5 or CXCR4. Seven of the isolates used CMKRL1 for viral entry; they were mainly of the syncytium-inducing phenotype and also used CXCR4. Entry efficiency was higher with CMKRL1 than with CXCR4 for more than half of these isolates. Three of the ten isolates did not use CMKRL1; instead, entry was mediated by both CCR5 and CXCR4. The experiments thus indicate that CMKRL1 functions as a coreceptor for the entry of HIV-1 into CD4-positive cells. In the course of this study, leukotriene B4 was shown to be the natural ligand for this receptor (now designated BLTR), which therefore represents a novel type of HIV-1 coreceptor along with the previously identified chemokine receptors. BLTR belongs to the same general chemoattractant receptor family as the chemokine receptors but is structurally more distant from them than are any of the previously described HIV-1 coreceptors.
机译:最近克隆的人类趋化因子受体样(CMKRL)1在CD4阳性免疫细胞中体内表达,与两个趋化因子受体CC趋化因子受体(CCR)5和CXC趋化因子受体(CXCR)4具有结构同源性。作为将HIV-1包膜与靶细胞融合所必需的主要受体。鉴于结构上的相似性,在携带人CD4受体的鼠成纤维细胞中稳定表达后,测试了CMKRL1作为另一种HIV-1受体的可能功能。用10个主要的HIV-1临床分离株感染细胞,并通过病毒DNA的半定量PCR监测进入情况。将进入的效率与在表达CCR5或CXCR4的CD4阳性细胞中发生的进入进行了比较。七个分离株使用CMKRL1进行病毒进入。它们主要是合胞体诱导表型,也使用了CXCR4。对于这些分离株的一半以上,CMKRL1的进入效率高于CXCR4。十个分离株中有三个未使用CMKRL1。相反,进入是由CCR5和CXCR4介导的。因此,实验表明CMKRL1充当HIV-1进入CD4阳性细胞进入的共受体。在这项研究过程中,白三烯B4被证明是该受体的天然配体(现称为BLTR),因此代表一种新型的HIV-1共受体和先前确定的趋化因子受体。 BLTR与趋化因子受体属于相同的一般趋化因子受体家族,但与先前描述的任何HIV-1共受体相比,BLTR在结构上与它们的距离更远。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号